Toronto StarFDA finds contamination issues at GSK vax plantFiercePharma ManufacturingThe FDA has sent a scathing warning letter to GlaxoSmithKline’s ($GSK) influenza vaccine plant in Quebec City, Canada, saying it is not doing near enough to avoid contamination of products there. It said GSK has had ongoing problems with bacteria at the …GSK warned over Quebec flu vaccine plantMetroNews CanadaFDA warns GSK on manufacturing practices at Canada plantGlobalPostall 21 news articles …Read Full Story
FDA finds contamination issues at GSK vax plant - FiercePharma Manufacturing
Real Estate of Cebu
